As of late 2025, over 200 human studiesincluding dozens of randomized controlled trials (RCTs)demonstrate that tPBM is safe, well-tolerated, and remarkably effective across a spectrum of brain disorders that have long defied conventional pharmacology: traumatic brain injury (TBI), stroke, major depressive disorder (MDD), Alzheimers disease (AD), Parkinsons disease (PD), autism spectrum disorder (ASD), post-COVID neurological sequelae, and even complex inflammatory conditions such as chronic Lyme disease and mold-related biotoxin illness.
For substances like DSIP, which may play a role in promoting sleep and stress regulation, such expedient delivery has the potential to enhance its efficacy
Research on Depression and Mitochondrial Function In hypoxic research settings, DSIP has been observed to potentially preserve mitochondrial function and influence serotonin regulation
Drug Resist Updat 19 , 112 (2015)
The following is a sample of the questions most commonly asked: It became clear that the initial financial model was not adequate for answering these questions
Don Catlin, worked to identify and expose these substances leading to one of the largest anti-doping scandals ever with the BALCO affair in 2002